| Names | |
|---|---|
|
IUPAC name
2-(Pentylamino)acetamide
|
|
| Identifiers | |
|
3D model (JSmol)
|
|
| ChemSpider | |
| MeSH | [www.nlm.nih.gov/cgi/show_data.php?acc={{{MeSH}}} {{{MeSH}}}] |
|
PubChem CID
|
|
| UNII | |
|
|
|
|
| Properties | |
| C7H16N2O | |
| Molar mass | 144.22 g·mol−1 |
| log P | 0.754 |
| Related compounds | |
|
Related compounds
|
Tricine |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
Milacemide (INN) is an MAO-B inhibitor and glycine prodrug. It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease. Early clinical trials did not show positive results however, and the drug is now abandoned.